Stay updated on Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1.0%
    Check dated 2025-02-24T23:23:22.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    1.0%
    Check dated 2025-02-10T17:53:46.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T12:53:35.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-01-27T08:45:14.000Z thumbnail image
  9. Check
    65 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-20T04:56:22.000Z thumbnail image
  10. Check
    72 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.2%
    Check dated 2025-01-13T00:32:08.000Z thumbnail image

Stay in the know with updates to Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.